Lori Anne Kunkel, Director of Enliven Therapeutics ELVN, has filed 0 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $345.4K. The latest trade was on 06/05.

LK

LK

Lori Anne Kunkel

Director

Company

Enliven Therapeutics ELVN

First filing

23/05/04

Trades

26 trades

Buys / sales

0 / 3

12-month net buying

−$345.4K

Last trade

06/05

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Enliven TherapeuticsELVN	Open-market sale10b5-1 plan	06/05	06/09	10,000 sh3 trades	$34.54avg.	$345,361.52	−16.2%